PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 66 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

21 September 2024

  1. (diff | hist) 04:23 TRIUMPH trial programme 1,217 ±0 DataTableDunja (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]

20 September 2024

  1. (diff | hist) 20:05 C-peptide 2,172 +280 DEXA_Dilys (talk | contribs) alphabetise the see-also list [rollback]
  2. (diff | hist) 19:34 Glossary of peptide terminology 2,317 ±0 DrTitration (talk | contribs) add the cross-link to the parent article [rollback]
  3. (diff | hist) 19:08 PeptideMeter 2,727 +673 RfC_Rasmus (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  4. (diff | hist) m 17:26 Dulaglutide 1,910 ±0 PeakShapePol (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  5. (diff | hist) 17:06 SELECT trial 2,300 +512 SourceHunterSile (talk | contribs) give the primary endpoint as pre-specified, not as reported [rollback]
  6. (diff | hist) 16:25 LEADER trial 1,964 +844 FlowTrialFraser (talk | contribs) consistent en dashes in ranges [rollback]
  7. (diff | hist) m b 15:52 Haemoglobin A1c 2,574 +31 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  8. (diff | hist) m 14:37 Beta cell function 2,291 ±0 ReceptorRhoda (talk | contribs) expand §Change under treatment and weight loss [rollback]
  9. (diff | hist) m b 10:42 GLP-1 receptor agonist 5,536 ±0 CiteBot (talk | contribs) bot: add drug-class category [rollback]
  10. (diff | hist) N 09:00 Sterility testing 1,908 +1,908 HOMA_Hettie (talk | contribs) new article: analytical method, expansion welcome
  11. (diff | hist) m 08:54 ISO 9001 1,967 +380 ImportPolicyIggy (talk | contribs) add the jurisdiction to the legal statement [rollback]
  12. (diff | hist) 08:48 Resin cleavage 2,363 +278 RepackRadek (talk | contribs) split overlong sentence [rollback]
  13. (diff | hist) 03:00 VendorInvestigate 2,190 ±0 BlankVialBo (talk | contribs) state what the certificate actually carries, field by field [rollback]

19 September 2024

  1. (diff | hist) 23:02 Cold chain 10,813 +575 CrossRefCleve (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  2. (diff | hist) m b 22:20 List of GLP-1 receptor agonists 2,257 +373 CiteBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) m 16:51 STEP trial programme 3,324 +112 StudentSindhu (talk | contribs) expand §The constituent trials [rollback]
  4. (diff | hist) 14:25 Amylin 1,974 +705 SarcopeniaSefa (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  5. (diff | hist) m 12:24 Arcuate nucleus 1,271 ±0 AmylinAmos (talk | contribs) add a figure for the secretion time course and caption it [rollback]
  6. (diff | hist) 10:46 Preparative HPLC purification 2,308 +38 ThymosinTamsin (talk | contribs) fix a broken wikilink [rollback]
  7. (diff | hist) 09:45 Crude peptide 1,870 +782 CustomsClarke (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  8. (diff | hist) N 09:00 Trifluoroacetate counterion 2,098 +2,098 BacWaterBarnaby (talk | contribs) start article on the analytical method

18 September 2024

  1. (diff | hist) 23:53 Nantong Guangyuan Chemical 5,037 +747 KPV_Kester (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  2. (diff | hist) N 17:54 Liquid chromatography-mass spectrometry 1,347 +1,347 MassSpecMarv (talk | contribs) new article: analytical method, expansion welcome
  3. (diff | hist) m 15:42 Retention time 1,620 ±0 GroupBuyGalen (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  4. (diff | hist) m 11:25 Insulin syringe 2,649 +29 KarlFischerKit (talk | contribs) ce, tighten prose [rollback]
  5. (diff | hist) N 06:20 TRIUMPH trial programme 1,217 +1,217 FreightFenna (talk | contribs) create article — trial programme stub
  6. (diff | hist) m 04:55 Electrospray ionisation 1,979 +653 ColumnOvenCoy (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]

17 September 2024

  1. (diff | hist) 23:12 Timeline of incretin therapeutics 2,352 +166 TriumphThad (talk | contribs) rm a duplicated category [rollback]
  2. (diff | hist) m 21:57 GLP-1 receptor 3,867 +153 ArcuateArt (talk | contribs) split §Physiology from §Pharmacological exploitation [rollback]
  3. (diff | hist) m 20:38 Third-party testing 3,553 +140 ImageReuseIris (talk | contribs) add the turnaround time the service publishes [rollback]
  4. (diff | hist) 14:14 Bacterial endotoxin test 2,127 ±0 AnalyticalAnnie (talk | contribs) split overlong sentence [rollback]
  5. (diff | hist) 11:01 Qingdao Sigma Chemical 2,804 +592 ChainCustodyChad (talk | contribs) add the lead time for catalogue lines, as reported [rollback]
  6. (diff | hist) m 10:12 Janoshik Analytical 2,844 ±0 SecondarySrc_Seb (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]
  7. (diff | hist) 10:08 Solid-phase peptide synthesis 2,718 +108 ForestPlotFinn (talk | contribs) correct the eutectic temperature — source gives a range [rollback]
  8. (diff | hist) N 09:00 Arcuate nucleus 1,271 +1,271 MetricMabel (talk | contribs) new article: incretin physiology, expansion welcome
  9. (diff | hist) N 09:00 Blind sampling 2,941 +2,941 Peptide_Pete (talk | contribs) start article on the testing subject
  10. (diff | hist) m 06:08 Dual incretin agonist 3,231 +40 ReportReaderRilla (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  11. (diff | hist) m 04:34 Weight regain after discontinuation 1,814 ±0 BiliaryBea (talk | contribs) add the perioperative consideration with the society guidance it comes from [rollback]
  12. (diff | hist) m 01:25 Reference standard 2,872 ±0 ColdChainCleo (talk | contribs) ce [rollback]

16 September 2024

  1. (diff | hist) 23:49 GL Biochem (Shanghai) 6,397 +1,072 ShortageShona (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  2. (diff | hist) 20:48 Lyophilisation 4,024 ±0 ColdChainCleo (talk | contribs) rm a duplicated category [rollback]
  3. (diff | hist) 19:35 Wuhan Wansheng Biotechnology 5,546 +344 BatchNumberBede (talk | contribs) copyedit [rollback]
  4. (diff | hist) 19:06 SURMOUNT trial programme 2,567 +31 Retention_Time_Rae (talk | contribs) state the non-inferiority margin, since the design was non-inferiority [rollback]
  5. (diff | hist) 18:27 Guangzhou JEEP Biotechnology 4,643 +33 ReportReaderRilla (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  6. (diff | hist) 03:39 Adverse effects of GLP-1 receptor agonists 3,137 ±0 DulaglutideDug (talk | contribs) correct the severity grading scale named [rollback]
  7. (diff | hist) 02:37 Fmoc chemistry 2,652 ±0 SafetySignalSid (talk | contribs) add the collapse-temperature point, sourced [rollback]

15 September 2024

  1. (diff | hist) m 20:53 Lot traceability 2,212 +36 OralSemaOswin (talk | contribs) rm a duplicated category [rollback]
  2. (diff | hist) 17:34 Peptide content 1,955 +682 AnalyticalAnnie (talk | contribs) clarify that area percent is not mass percent [rollback]
  3. (diff | hist) m 12:22 Peptide synthesis 2,919 +121 CDMO_Caradoc (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  4. (diff | hist) 11:32 Vial 7,798 +1,039 FreightFenna (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]
  5. (diff | hist) 08:42 Bacteriostatic water 2,807 ±0 UnitsUrsula (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  6. (diff | hist) m b 08:10 Liraglutide 2,493 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  7. (diff | hist) 05:15 Insulin secretion 2,712 +352 DeadSpaceDot (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]
  8. (diff | hist) 04:08 Receptor bias 1,938 ±0 DeadSpaceDot (talk | contribs) add the species in which the knockout work was done [rollback]
  9. (diff | hist) m 03:21 High-performance liquid chromatography 3,326 +147 Peptide_Pete (talk | contribs) add category for method validation [rollback]

14 September 2024

  1. (diff | hist) m b 21:16 Oral semaglutide 2,129 ±0 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]
  2. (diff | hist) 19:35 Proglucagon 2,929 +227 SatietySunniva (talk | contribs) the glucose-dependence of the insulinotropic effect deserves its own sentence [rollback]
  3. (diff | hist) 18:08 Subcutaneous injection 2,928 +836 BUD_Bertram (talk | contribs) move a stray full stop inside the reference [rollback]
  4. (diff | hist) m 14:34 Chain of custody 2,414 ±0 MarginNoteMars (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]
  5. (diff | hist) m 13:36 Limit of detection 2,557 +815 CRP_Cormac (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  6. (diff | hist) m 11:18 Chinese Peptide Company 4,118 +696 NPOV_Nadia (talk | contribs) expand §Product range [rollback]
  7. (diff | hist) N 09:00 Fasting insulin 1,061 +1,061 UnitsUrsula (talk | contribs) start article; reference intervals to follow
  8. (diff | hist) 08:52 Talk:Qingdao Sigma Chemical 1,033 +91 SourceHunterSile (talk | contribs) /* Attributed founding year versus registry record */ reply
  9. (diff | hist) 04:53 Weight regain after discontinuation 1,814 +613 LeanMassLars (talk | contribs) expand §Interpretation [rollback]
  10. (diff | hist) 03:25 Medutest 2,675 +138 GroupBuyGalen (talk | contribs) add the turnaround time the service publishes [rollback]
  11. (diff | hist) m 03:11 Good manufacturing practice 1,773 ±0 GMP_Gita (talk | contribs) add the effective date to the regulatory table [rollback]
  12. (diff | hist) m 00:36 Satiety signalling 2,170 ±0 HalfLifeHavel (talk | contribs) ce, tighten prose [rollback]

13 September 2024

  1. (diff | hist) m 22:44 Mass spectrometry 2,880 ±0 TFA_Counterion (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]
  2. (diff | hist) 20:27 WuXi TIDES 4,401 +179 BlindSampleBrid (talk | contribs) unpipe a link that did not need piping [rollback]
  3. (diff | hist) m 20:04 VendorInvestigate 2,190 ±0 Retention_Time_Rae (talk | contribs) add the retest interval and what triggers one [rollback]
  4. (diff | hist) m 18:59 Research use only 3,193 +314 CagriCass (talk | contribs) split the compounding position from the manufacturing position [rollback]
  5. (diff | hist) 16:08 Area percent purity 2,608 +767 MassSpecMarv (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  6. (diff | hist) 15:52 Dipeptidyl peptidase-4 3,295 ±0 GsCouplingGil (talk | contribs) expand §Catalytic action and substrate range [rollback]
  7. (diff | hist) m 13:34 Residual solvent 1,962 ±0 SigFigSindri (talk | contribs) expand §Classes and limits [rollback]
  8. (diff | hist) m b 12:57 Analytical method validation 2,979 +540 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  9. (diff | hist) m 12:28 Semaglutide 5,011 +154 GHK_Gwendolen (talk | contribs) rm a duplicated category [rollback]
  10. (diff | hist) 09:54 Certificate of analysis 2,872 ±0 AnalyticalAnnie (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  11. (diff | hist) N 09:00 Chain of custody 2,414 +2,414 LotTraceLuka (talk | contribs) create article — testing stub

12 September 2024

  1. (diff | hist) 18:58 PeptideMeter 2,054 ±0 NNT_Nerys (talk | contribs) add the note that a purity figure without water and counterion is not a mass [rollback]
  2. (diff | hist) 16:19 LEADER trial 1,120 ±0 PioneerPerdita (talk | contribs) British spelling per PP:MOS [rollback]
  3. (diff | hist) m 14:43 ISO 9001 1,587 ±0 SemaglutideSasha (talk | contribs) expand §What it implies about material [rollback]
  4. (diff | hist) 14:39 Hunan Aslsen Technology 1,705 ±0 TallySheetTad (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  5. (diff | hist) 11:42 Glucagon-like peptide-1 5,965 +138 SemaglutideSasha (talk | contribs) rm the sentence implying the hormone is a drug [rollback]
  6. (diff | hist) N 10:37 Crude peptide 1,088 +1,088 CDMO_Caradoc (talk | contribs) new article: supply and handling, expansion welcome
  7. (diff | hist) 09:18 Talk:Qingdao Sigma Chemical 822 +111 Hedgerow_Hal (talk | contribs) /* Attributed founding year versus registry record */ reply
  8. (diff | hist) N 09:00 Receptor bias 1,938 +1,938 ChromCleanupCass (talk | contribs) start article on the hormone
  9. (diff | hist) 08:51 Talk:Research use only 822 +129 Compounding_Cate (talk | contribs) /* Should the warning box be a banner instead? */ reply
  10. (diff | hist) 08:06 Batch number 2,461 +468 PurityClaimPia (talk | contribs) expand §Consistency checks [rollback]
  11. (diff | hist) 06:20 Injection site rotation 2,155 +574 INN_Ingrid (talk | contribs) expand §Rotation schemes [rollback]
  12. (diff | hist) 03:06 Reconstitution of lyophilised peptides 2,961 +107 LyophilLena (talk | contribs) state that swirling rather than shaking is the handling convention, sourced [rollback]
  13. (diff | hist) N 02:22 Dulaglutide 1,910 +1,910 StopperingSteff (talk | contribs) new article: compound, expansion welcome

11 September 2024

  1. (diff | hist) 14:03 Talk:Research use only 611 +245 Hedgerow_Hal (talk | contribs) /* Should the warning box be a banner instead? */ reply
  2. (diff | hist) 13:44 Talk:Qingdao Sigma Chemical 611 +242 NotabilityNoa (talk | contribs) /* Attributed founding year versus registry record */ reply
  3. (diff | hist) 10:26 Talk:Qingdao Sigma Chemical 400 +279 SourceHunterSile (talk | contribs) /* Attributed founding year versus registry record */ new section
  4. (diff | hist) 10:26 Talk:Research use only 400 +193 DefinedTermDov (talk | contribs) /* Should the warning box be a banner instead? */ new section
  5. (diff | hist) 00:01 Karl Fischer titration 4,173 +37 INN_Ingrid (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]

10 September 2024

  1. (diff | hist) 23:18 Glucose-dependent insulinotropic polypeptide 5,034 +688 GsCouplingGil (talk | contribs) clarify that concentrations differ substantially between assay platforms [rollback]
  2. (diff | hist) N 19:51 Injection site rotation 1,581 +1,581 FlowTrialFraser (talk | contribs) new article: dosing and handling, expansion welcome
  3. (diff | hist) 16:58 Reverse-phase HPLC 3,012 ±0 TFA_Counterion (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]